Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Apply for the "Course of Excellence in Oncology - Fondation Philanthropia"
Gustave Roussy, the leading comprehensive cancer centre in Europe, is now recruiting for its 5th round for the “Course of Excellence in Oncology - Fondation Philanthropia”.
Published on
Changed on
Gustave Roussy, the leading comprehensive cancer centre in Europe, is now recruiting for its 5th round for the "Course of Excellence in Oncology - Fondation Philanthropia". Doctors, pharmacists and engineers from France and from all over the world who have a Masters degree or equivalent are invited to participate in an unprecedented drive for progress in tackling cancer. This year, 4 high-potential candidates will be chosen to undertake their doctorate degree in a state-of-the-art laboratory at Gustave Roussy, at the heart of France’s Grand Paris.
Established with the support of the Fondation Philanthropia within the School of Cancer Sciences (Gustave Roussy/University Paris-Sud), this programme invests in oncology training for the upcoming generation, which is an essential condition for ensuring the constant renewal of innovations, in both research and care, to push back cancer.
The "Course of Excellence in Oncology – Fondation Philanthropia" at Gustave Roussy is a 3 year course offering made-to-measure training in research every year in one of the most advanced oncology research laboratories in the world. The Course of Excellence in Oncology has already hosted 14 promising and talented researchers for their doctorate degree.
Strong scientific mentoring
Successful candidates will join a team of researchers from Gustave Roussy to undertake their doctorate in those fields where treatment of cancer is being revolutionised, such as immunotherapy, molecular medicine and DNA repair. They will be at the heart of an integrated research centre that incorporates fundamental, translational and clinical research.
Each young researcher will be inspired by a strong, ambitious team spirit, and will be supervised and mentored by some of the top names in research, in addition to benefitting from potential collaboration with other international centres of excellence. He/she will be paid over the three-year period of the research contract at a rate of around 2,300 euros per month net, with health insurance included.
Applications are now open
- Apply by 15 February 2017 at www.phd-in-oncology.com.
Last news
-
Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction
On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.
-
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide
The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
-
Living with and beyond cancer: the promises and challenges of digital health
In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings.
-
Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care
The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.
